232
Participants
Start Date
April 4, 2001
Primary Completion Date
April 9, 2014
Study Completion Date
September 15, 2023
Chemotherapy
Docetaxel (Taxotere®) 85 mg/m2 1 hour iv infusion d1 Cisplatin 100 mg/m2 1 hour iv infusion d1 Schedule: 3 cycles repeated every 21 days
Radiotherapy
Radiotherapy (3 weeks after last chemotherapy administration) 44 Gy in 22 fractions concomitant boost technique in 3 weeks
Surgery
3-4 weeks after termination of radiotherapy
Centre Pluridisciplinaire d' Oncologie, Lausanne
Kantonsspital Freiburg, Fribourg
Regionalspital, Thun
FMH Onkologie/Haematologie, Rheinfelden
Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli, Bellinzona
Onkozentrum, Zurich
Institut za plucne bolesti, Kamenitz
Institute of Oncology, Kamenitz
Klinik Loewenstein gGmbH, Löwenstein
Klinikum der Stadt Mannheim, Mannheim
Kantonsspital Aarau, Aarau
Kantonsspital Baden, Baden
Kantonsspital, Baden
Saint Claraspital AG, Basel
Universitaetsspital-Basel, Basel
Inselspital Bern, Bern
Kantonsspital Bruderholz, Bruderholz
Kantonsspital Graubuenden, Chur
Hopital Cantonal Universitaire de Geneve, Geneva
Kantonsspital Liestal, Liestal
Kantonsspital Olten, Olten
Kantonsspital - St. Gallen, Sankt Gallen
Kantonsspital Winterthur, Winterthur
City Hospital Triemli, Zurich
UniversitaetsSpital Zuerich, Zurich
Swiss Cancer Institute
OTHER